Controversy still swirls around FDA user fees: Since 1992, the prescription drug user fee act and reauthorizations have sped up new drug approvals-but does speed equal safety?

2013 ◽  
Vol 74 (5) ◽  
pp. A10-A11
Author(s):  
Kurt Ullman
Keyword(s):  
Prescription Drug ◽  
Drug User ◽  
User Fees ◽  
New Drug ◽  
Prescription Drug User ◽  
User Fee ◽  
Drug Approvals

FDA New Drug Approval Times, Prescription Drug User Fees, and R&D Spending

2006 ◽  
Author(s):  
Joseph H. Golec ◽  
John A. Vernon ◽  
Randall Lutter ◽  
Clark Nardinelli
Keyword(s):  
Prescription Drug ◽  
Drug User ◽  
Drug Approval ◽  
User Fees ◽  
New Drug ◽  
Prescription Drug User

An exploratory study of FDA new drug review times, prescription drug user fee acts, and R&D spending

2009 ◽  
Vol 49 (4) ◽  
pp. 1260-1274 ◽  
Author(s):  
John A. Vernon ◽  
Joseph H. Golec ◽  
Randall Lutter ◽  
Clark Nardinelli
Keyword(s):  
Prescription Drug ◽  
Drug User ◽  
Exploratory Study ◽  
New Drug ◽  
Prescription Drug User ◽  
User Fee ◽  
Drug Review

Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts

2008 ◽  
Vol 92 (5-6) ◽  
pp. 1306-1325 ◽  
Author(s):  
Tomas Philipson ◽  
Ernst R. Berndt ◽  
Adrian H.B. Gottschalk ◽  
Eric Sun
Keyword(s):  
Prescription Drug ◽  
Drug User ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis ◽  
Prescription Drug User ◽  
User Fee
Sign in / Sign up

Export Citation Format

Share Document